Avinger Inc
DelistedCIK 1506928fmd_1SCYPQWFD31CGX58ZKF2320CB9Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2024, 44 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 11 | 11 | 19 | 10 | 8 | 9 | 9 | 10 | 8 | 8 |
| Cost of revenue | 7 | 6 | 14 | 13 | 7 | 6 | 6 | 7 | 6 | 6 |
| Gross profit | 5 | 4 | 5 | (3) | 1 | 3 | 3 | 3 | 3 | 2 |
| Research and development | 11 | 16 | 16 | 11 | 6 | 6 | 6 | 6 | 4 | 5 |
| Selling, general and administrative | 19 | 29 | 40 | 25 | 18 | 17 | 14 | 16 | 14 | 14 |
| Total operating expenses | 30 | 45 | 55 | 39 | 24 | 22 | 20 | 22 | 19 | 19 |
| Operating income | (25) | (41) | (51) | (43) | (23) | (19) | (17) | (18) | (16) | (17) |
| Interest expense | 6 | 5 | 6 | 6 | 6 | 1 | 2 | 2 | 2 | 2 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | (1) | (2) | (0) | 0 | 1 | 1 | 0 | 2 | (0) | 0 |
| Income before taxes | (32) | (47) | (56) | – | – | – | – | – | – | – |
| Income tax expense | 0 | – | – | – | – | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (32) | – | – | – | – | – | – | – | – | – |
| Net income | (32) | (47) | (56) | (49) | (28) | (19) | (19) | (17) | (18) | (18) |
| Net income to common shareholders | (32) | (50) | (56) | (49) | (36) | (23) | (23) | (22) | (27) | (18) |